Table 2.

Retained clinical conditions and QOF indicators (care bundles and components)

	Secondary prevention of Coronary Heart Disease (CHD)
	The percentage of patients with coronary heart disease:
CHD6	…in whom the last blood pressure reading (measured in the previous 15 months) is 150/90 or less
CHD8	…whose last measured total cholesterol (measured in the previous 15 months) is 5 mmol/l or less
CHD9	…with a record in the previous 15 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
CHD10	…who are currently treated with a beta blocker (unless a contraindication or side-effects are recorded)
CHD11	…a history of myocardial infarction (diagnosed after 1 April 2003) who are currently treated with an ACE inhibitor or Angiotensin II antagonist
CHD12	…who have a record of influenza immunisation in the preceding 1 September to 31 March
	Chronic kidney disease (CKD)
	The percentage of patients on the CKD register:
CKD3	…whom the last blood pressure reading, measured in the previous 15 months, is 140/85 or less
CKD5	…with hypertension and proteinuria who are treated with an angiotensin converting enzyme inhibitor (ACE – I) or angiotensin receptor blocker (ARB) (unless a contraindication or side effects are recorded)
CKD6	…whose notes have a record of a urine albumin: creatinine ratio (or protein: creatinine ratio) test in the previous 15 months
	Diabetes mellitus (DM)
	The percentage of patients with diabetes:
DM2	…whose notes record BMI in the previous 15 months
DM24	…in whom the last HbA1c is 8 or less (or equivalent test/reference range depending on local laboratory) in the previous 15 months
DM9	…with a record of the presence or absence of peripheral pulses in the previous 15 months
DM10	…with a record of neuropathy testing in the previous 15 months
DM12	…in whom the last blood pressure is 145/85 or less
DM15	…with a diagnosis of proteinuria or micro-albuminuria who are treated with ACE inhibitors (or A2 antagonists)
DM17	…whose last measured total cholesterol within the previous 15 months is 5 mmol/l or less
DM18	…who have had influenza immunisation in the preceding 1 September to 31 March
	Chronic obstructive pulmonary disease (COPD)
	The percentage of patients with COPD:
COPD10	…with a record of FeV1 in the previous 15 months
COPD13	…who have had a review, undertaken by a healthcare professional, including an assessment of breathlessness using the MRC dyspnoea score in the preceding 15 months
COPD8	…who have had influenza immunisation in the preceding 1 September to 31 March
	Stroke and transient ischaemic attack (Stroke/TIA)
	The percentage of patients with:
STROKE6	…a history of TIA or stroke in whom the last blood pressure reading (measured in the previous 15 months) is 150/90 or less
STROKE8	…TIA or stroke whose last measured total cholesterol (measured in the previous 15 months) is 5 mmol/l or less
STROKE12	… with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), m or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
STROKE10	…TIA or stroke who have had influenza immunisation in the preceding 1 September to 31 March